Recalls & Warnings January 28, 2025 Shatavari Powder Recalled Due to Risk of Lead Contamination On January 27, 2025, New York Wholesale Group recalled Zaarah Herbals shatavari powder because of potential lead contamination
Clinical evidence from cardiovascular outcomes trials and post-marketing surveillance indicates that GLP-1 receptor agonists are associated with modest increases in resting heart rate
Dosing Guide Full titration protocol from 2mg to 12mg
Readers should be aware that the regulatory treatment of BPC-157 involves ongoing complexity, and should review current FDA and other applicable guidance before purchase or use
I started GLP-1 because I thought it would make my life easier, since I feared continuing my pattern of compulsive eating and losing control over my body
If your insurance plan doesnt cover a drug, that doesnt mean that you cant receive care